Multiple Antigen Stimulating Cellular Therapy (MASCT) For Hepatocellular Carcinoma After Curative Treatment: A Retrospective Study

Background & Aims: The prognosis of hepatocellular carcinoma (HCC) remains poor and available treatment options are limited. This retrospective study evaluated the efficacy of Multiple Antigen Stimulating Cell Therapy (MASCT) as an adjuvant therapy for the treatment of HCC after curative treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yajing, Guo, Yabing, Chen, Jinzhang, Hu, Xiaoyun, Li, Xiaoshuang, Kong, Yanjun, Zhang, Xiaoyong, Zhou, Xiangjun, Liu, Li, Hou, Jinlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929083/
https://www.ncbi.nlm.nih.gov/pubmed/29721048
http://dx.doi.org/10.7150/jca.23725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929083/
https://www.ncbi.nlm.nih.gov/pubmed/29721048
http://dx.doi.org/10.7150/jca.23725

Ejemplares similares